Skip to content

Pregnancy With Insomnia: a Trial of Acupuncture

Pregnancy With Insomnia: a Trial of Acupuncture

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03194191
Acronym
GAS
Enrollment
60
Registered
2017-06-21
Start date
2017-09-30
Completion date
2019-05-31
Last updated
2017-06-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Insomnia

Keywords

Insomnia, Pregnancy, Acupuncture, Insomnia severity index, Pittsburgh Sleep Quality Index, Anxiety, Depression

Brief summary

Acupuncture is widely used for treatment of insomnia. The research hypothesis is that acupuncture may be more effective than sham acupuncture to treat insomnia during pregnancy. GAS is a randomized controlled trial with placebo acupuncture using the insomnia severity index (ISI) as the main outcome criterion.

Detailed description

Scientific justification: \- During pregnancy, insomnia occurs mainly in women without a previous history of sleep disorder, and may remain after delivery. Insomnia affects the quality of life. It might be associated with an increase in labor duration and cesarean section rate. Insomnia tends to worsen during gestation, owing to back pain, an increased need to micturate, and the movement of the fetus. Sleep disorders are often associated with restless legs syndrome. * To treat insomnia during pregnancy, the Haute Autorité de Santé (HAS) recommends avoiding using psychotropic medications. It also recommends screening for depression or anxiety traits often associated with insomnia. However, in most cases, psychological means alone fail to treat insomnia effectively. * Based on 11 randomized controlled trials, the odds of improving sleep disorders are 3 times greater with than without acupuncture, but the methodological quality of these trials is considered insufficient to conclude. Population: The study focused on pregnant women suffering from insomnia, excluding women with pregnancies complicated by pre-eclampsia, fetal growth anomalies, or threatened premature labor for fear those complications might interact with sleep disorders, as well as women with known psychiatric disorders. We also excluded women with a history of insomnia before pregnancy to focus on insomnia triggered by pregnancy only. Objectives: * Primary objective: To assess the effect of a standardized acupuncture protocol vs. placebo on insomnia during pregnancy. * Secondary objectives: To assess the effect of a standardized acupuncture protocol vs. placebo on (i) the Pittsburgh Sleep Quality Index (PSQI), (ii) anxiety and depression traits, (iii) use of psychotropic medicines and (iv) recreational substances, (v) the incidence of restless legs syndrome, (vi) perinatal outcome . Study design: * Study Type: Multicentre, Interventional, randomized, 2 parallel groups * Endpoint Classification: Efficacy Study * Intervention Model: Parallel Assignment * Masking: Single blind (patient blinded to intervention) * Primary Purpose: Treatment * One acupuncture session weekly for 4 consecutive weeks Visits: * Selection: When a pregnant woman complains from insomnia, the health professional in charge will fill a checklist of inclusion and exclusion criteria, provide the patient with a pre inclusion ISI questionnaire and give the patient an information sheet and a copy of the consent. When a pregnant woman is sent to the acupuncturist for sleep disorders, he or she may proceed to the selection visit. * Inclusion: The acupuncturist checks for inclusion and exclusion criteria, collects the patient written consent, performs the clinical examination, gives the corresponding self-assessment questionnaires and proceeds to computerized randomization. * Follow-up: At visits 1 to 4, the acupuncturist performs the treatment, and records side effects if any. Visits are scheduled on a weekly basis. * End of research: At visit 5 (one week after last acupuncture session), the acupuncturist gives the corresponding self-assessment questionnaires.

Interventions

The patient will be in a semi recumbent position during needle penetration. Duration of needle insertion: 30 minutes

Sponsors

Assistance Publique - Hôpitaux de Paris
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Masking description

Single blind (patient blinded to intervention)

Intervention model description

Randomized controlled trial with regular acupuncture needles vs. sham needles. In addition, the sham needles will be placed in areas that do not correspond to any known acupuncture point. 5 bilateral acupoints or placebo acupoints,

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Age \> 18 years * Singleton pregnancy * Gestational age ≥ 16 weeks + 0 day and ≤ 32 weeks + 6 days * Insomnia Severity Index ≥ 10 * Insomnia reported to have started during pregnancy and at least 2 weeks before inclusion * Patient understanding the study * Informed consent signed * Social insurance available at inclusion and until the end of pregnancy

Exclusion criteria

* Threatened premature labor * Small fetus for gestational age * Pre-eclampsia * Insomnia starting before pregnancy * Use of psychotropic drugs before pregnancy * Use of recreational drugs during pregnancy * Known psychiatric disorder * Anticoagulant therapy * Patient reporting insomnia results from chronic or acute pain * Obstructive sleep apnea (OSA) requiring treatment * Patient under antidepressant therapy * Patient under legal guardianship or deprived of freedom

Design outcomes

Primary

MeasureTime frameDescription
Insomnia severity index (ISI)Inclusion visit and 5 weeks after the first acupuncture sessionDifference of ISI self-report questionnaire administrated at inclusion visit and 5 weeks after the first acupuncture session

Secondary

MeasureTime frameDescription
Pittsburgh Sleep Quality Index (PSQI)Inclusion visit and 5 weeks after the first acupuncture sessionDifference of PSQI self-report questionnaire administrated at inclusion visit and 5 weeks after the first acupuncture session
Hospital Anxiety and Depression Scale (HADS)Inclusion visit and 5 weeks after the first acupuncture sessionDifference of HADS self-report questionnaire administrated at inclusion visit and 5 weeks after the first acupuncture session
Cumulated dose of each psychotropic medicineInclusion visit and 5 weeks after the first acupuncture sessionDuring the study period, the patients will note on a logbook the daily use of any drug.
Cumulated dose of alcoholInclusion visit and 5 weeks after the first acupuncture sessionDuring the study period, the patients will note on a logbook the daily use of alcohol.
Cumulated dose of tobaccoInclusion visit and 5 weeks after the first acupuncture sessionDuring the study period, the patients will note on a logbook the daily use of tobacco.
Cumulated dose of cannabisInclusion visit and 5 weeks after the first acupuncture sessionDuring the study period, the patients will note on a logbook the daily use of cannabis.
Cumulated dose of other recreational substances or medicineInclusion visit and 5 weeks after the first acupuncture sessionDuring the study period, the patients will note on a logbook the daily use of other recreational substances and medicine.
Difference in the frequency of restless leg syndromeInclusion visit and 5 weeks after the first acupuncture sessionAccording to the guidelines of the International Restless Legs Syndrome Study Group. The diagnosis of restless leg will rely on the presence of all of the following criteria: 1. Desire to move the extremities usually associated with discomfort or disagreeable sensations in the extremities. 2. Motor Restlessness-patients move to relieve the discomfort, for example walking, or to provide a counter-stimulus to relieve the discomfort, for example, rubbing the legs. 3. Symptoms are worse at rest with at least temporary relief by activity. 4. Symptoms are worse later in the day or at night.
Perinatal outcome - Gestational age at birthAt birthThe gestational age at birth of the newborn will be recorded.
Perinatal outcome - birth weightAt birthThe weight (in gr) at birth of the newborn will be recorded.
Perinatal outcome - birth heightAt birthThe height (in cm) at birth of the newborn will be recorded.
Perinatal outcome - sexAt birthThe sex of the newborn will be recorded.
Perinatal outcome - perinatal mortalityAt birthThe perinatal mortality will be recorded.
Perinatal outcome - five minutes Apgar scoreAt birthThe five minutes Apgar score will be recorded.
Perinatal outcome - cesarean section rateAt birth.Cesarean section rate will be recorded.

Contacts

Primary ContactStéphanie Nicolian, Midewife
snicolian@yahoo.fr0033 6 25 71 08 64
Backup ContactMarc Dommergues, PUPH
marc.dommergues@aphp.fr0033 6 08 48 69 25

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026